
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka, Jacques Banchereau
Immunity (2013) Vol. 39, Iss. 1, pp. 38-48
Open Access | Times Cited: 792
Karolina Palucka, Jacques Banchereau
Immunity (2013) Vol. 39, Iss. 1, pp. 38-48
Open Access | Times Cited: 792
Showing 1-25 of 792 citing articles:
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen, Ira Mellman
Immunity (2013) Vol. 39, Iss. 1, pp. 1-10
Open Access | Times Cited: 5787
Daniel S. Chen, Ira Mellman
Immunity (2013) Vol. 39, Iss. 1, pp. 1-10
Open Access | Times Cited: 5787
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos, Kellie A. Charles, Donald C. McMillan, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 11, pp. e493-e503
Closed Access | Times Cited: 1867
Connie I. Diakos, Kellie A. Charles, Donald C. McMillan, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 11, pp. e493-e503
Closed Access | Times Cited: 1867
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay, Elizabeth P. Ryan, Graham Pawelec, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S185-S198
Open Access | Times Cited: 1413
Dass S. Vinay, Elizabeth P. Ryan, Graham Pawelec, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S185-S198
Open Access | Times Cited: 1413
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona, Eleftherios P. Diamandis, Ivan M. Blasutig
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 1074
Sofia Farkona, Eleftherios P. Diamandis, Ivan M. Blasutig
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 1074
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
Robert J. Johnston, Laëtitia Comps-Agrar, Jason A. Hackney, et al.
Cancer Cell (2014) Vol. 26, Iss. 6, pp. 923-937
Open Access | Times Cited: 1001
Robert J. Johnston, Laëtitia Comps-Agrar, Jason A. Hackney, et al.
Cancer Cell (2014) Vol. 26, Iss. 6, pp. 923-937
Open Access | Times Cited: 1001
The evolution of commercial drug delivery technologies
Ava M. Vargason, Aaron C. Anselmo, Samir Mitragotri
Nature Biomedical Engineering (2021) Vol. 5, Iss. 9, pp. 951-967
Open Access | Times Cited: 982
Ava M. Vargason, Aaron C. Anselmo, Samir Mitragotri
Nature Biomedical Engineering (2021) Vol. 5, Iss. 9, pp. 951-967
Open Access | Times Cited: 982
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Jérôme Galon, Helen K. Angell, Davide Bedognetti, et al.
Immunity (2013) Vol. 39, Iss. 1, pp. 11-26
Open Access | Times Cited: 791
Jérôme Galon, Helen K. Angell, Davide Bedognetti, et al.
Immunity (2013) Vol. 39, Iss. 1, pp. 11-26
Open Access | Times Cited: 791
Dendritic Cells and Cancer Immunity
Alycia Gardner, Brian Ruffell
Trends in Immunology (2016) Vol. 37, Iss. 12, pp. 855-865
Open Access | Times Cited: 783
Alycia Gardner, Brian Ruffell
Trends in Immunology (2016) Vol. 37, Iss. 12, pp. 855-865
Open Access | Times Cited: 783
The Basis of Oncoimmunology
Karolina Palucka, Lisa M. Coussens
Cell (2016) Vol. 164, Iss. 6, pp. 1233-1247
Open Access | Times Cited: 747
Karolina Palucka, Lisa M. Coussens
Cell (2016) Vol. 164, Iss. 6, pp. 1233-1247
Open Access | Times Cited: 747
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour, Michael Karin
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3347-3355
Open Access | Times Cited: 633
Shabnam Shalapour, Michael Karin
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3347-3355
Open Access | Times Cited: 633
Tumor Immunology and Tumor Evolution: Intertwined Histories
Jérôme Galon, Daniela Bruni
Immunity (2020) Vol. 52, Iss. 1, pp. 55-81
Open Access | Times Cited: 461
Jérôme Galon, Daniela Bruni
Immunity (2020) Vol. 52, Iss. 1, pp. 55-81
Open Access | Times Cited: 461
Classification of current anticancer immunotherapies
Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, et al.
Oncotarget (2014) Vol. 5, Iss. 24, pp. 12472-12508
Open Access | Times Cited: 443
Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, et al.
Oncotarget (2014) Vol. 5, Iss. 24, pp. 12472-12508
Open Access | Times Cited: 443
Smart nanoparticles for cancer therapy
Leming Sun, Hongmei Liu, Yanqi Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 390
Leming Sun, Hongmei Liu, Yanqi Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 390
Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
Aleksandra M. Dudek, Shaun Martin, Abhishek D. Garg, et al.
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 354
Aleksandra M. Dudek, Shaun Martin, Abhishek D. Garg, et al.
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 354
Antigen Presentation by Extracellular Vesicles from Professional Antigen-Presenting Cells
Marthe F. S. Lindenbergh, Willem Stoorvogel
Annual Review of Immunology (2018) Vol. 36, Iss. 1, pp. 435-459
Open Access | Times Cited: 313
Marthe F. S. Lindenbergh, Willem Stoorvogel
Annual Review of Immunology (2018) Vol. 36, Iss. 1, pp. 435-459
Open Access | Times Cited: 313
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof, Jurgen Corthals, Carlo Heirman, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 12, pp. 1330-1338
Closed Access | Times Cited: 290
Sofie Wilgenhof, Jurgen Corthals, Carlo Heirman, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 12, pp. 1330-1338
Closed Access | Times Cited: 290
Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells
Pierre Bourdely, Giorgio Anselmi, Kristīne Vaivode, et al.
Immunity (2020) Vol. 53, Iss. 2, pp. 335-352.e8
Open Access | Times Cited: 269
Pierre Bourdely, Giorgio Anselmi, Kristīne Vaivode, et al.
Immunity (2020) Vol. 53, Iss. 2, pp. 335-352.e8
Open Access | Times Cited: 269
Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine
Gaona Shi, Chuangnian Zhang, Rong Xu, et al.
Biomaterials (2016) Vol. 113, pp. 191-202
Open Access | Times Cited: 267
Gaona Shi, Chuangnian Zhang, Rong Xu, et al.
Biomaterials (2016) Vol. 113, pp. 191-202
Open Access | Times Cited: 267
High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization
Marcela Alcántara‐Hernández, Rebecca Leylek, Lisa E. Wagar, et al.
Immunity (2017) Vol. 47, Iss. 6, pp. 1037-1050.e6
Open Access | Times Cited: 262
Marcela Alcántara‐Hernández, Rebecca Leylek, Lisa E. Wagar, et al.
Immunity (2017) Vol. 47, Iss. 6, pp. 1037-1050.e6
Open Access | Times Cited: 262
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
Abhishek D. Garg, Lien Vandenberk, Carolien Koks, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 328
Closed Access | Times Cited: 254
Abhishek D. Garg, Lien Vandenberk, Carolien Koks, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 328
Closed Access | Times Cited: 254
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
Filippo Galli, Jesus Vera Aguilera, Belinda Palermo, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 232
Filippo Galli, Jesus Vera Aguilera, Belinda Palermo, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 232
Cancer vaccines
Lisa H. Butterfield
BMJ (2015) Vol. 350, Iss. apr22 14, pp. h988-h988
Open Access | Times Cited: 228
Lisa H. Butterfield
BMJ (2015) Vol. 350, Iss. apr22 14, pp. h988-h988
Open Access | Times Cited: 228
Macroscale biomaterials strategies for local immunomodulation
Maxence O. Dellacherie, Bo Ri Seo, David Mooney
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 379-397
Closed Access | Times Cited: 221
Maxence O. Dellacherie, Bo Ri Seo, David Mooney
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 379-397
Closed Access | Times Cited: 221
Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
Jianqin Lu, Xiangsheng Liu, Yu‐Pei Liao, et al.
ACS Nano (2018) Vol. 12, Iss. 11, pp. 11041-11061
Open Access | Times Cited: 215
Jianqin Lu, Xiangsheng Liu, Yu‐Pei Liao, et al.
ACS Nano (2018) Vol. 12, Iss. 11, pp. 11041-11061
Open Access | Times Cited: 215
Interleukin‐6/STAT 3 signaling as a promising target to improve the efficacy of cancer immunotherapy
Hidemitsu Kitamura, Yosuke Ohno, Yujiro Toyoshima, et al.
Cancer Science (2017) Vol. 108, Iss. 10, pp. 1947-1952
Open Access | Times Cited: 214
Hidemitsu Kitamura, Yosuke Ohno, Yujiro Toyoshima, et al.
Cancer Science (2017) Vol. 108, Iss. 10, pp. 1947-1952
Open Access | Times Cited: 214